Who Should Try New Antibody Treatments for Migraine?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Who Should Try New Antibody Treatments for Migraine?

Published:2018-09-01 Issue:9 Volume:75 Page:1039
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Loder Elizabeth W.¹²,Burch Rebecca C.²³

Affiliation:

1. Division of Headache, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts

2. Harvard Medical School, Boston, Massachusetts

3. John R. Graham Headache Center, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Reference9 articles.

1. New drugs that block brain peptide reduce migraine attacks, trials show.;Mayor;BMJ,2017

2. A comparative effectiveness meta-analysis of drugs for the prophylaxis of migraine headache.;Jackson;PLoS One,2015

3. Wiping out CGRP: potential cardiovascular risks.;MaassenVanDenBrink;Trends Pharmacol Sci,2016

4. The prevalence and impact of migraine and severe headache in the United States: figures and trends from government health studies.;Burch;Headache,2018

5. Shifts in intended and unintended pregnancies in the United States, 2001-2008.;Finer;Am J Public Health,2014

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Drug: Rimegepant for migraine;Australian Prescriber;2024-08-20

2. Migraine and cardiovascular disease: what cardiologists should know;European Heart Journal;2023-06-22

3. Examining the shared etiology of psychopathology with genome-wide association studies;Physiological Reviews;2023-04-01

4. CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond;Physiological Reviews;2023-04-01

5. Greater occipital nerve block for chronic migraine patients: A meta‐analysis;Acta Neurologica Scandinavica;2022-06-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3